尿管結石症におけるSB-502の疼痛軽減効果について -二重盲検法による比較試験-
スポンサーリンク
概要
- 論文の詳細を見る
The clinical effect of SB-502(N-butylscopolamine bromide 20 mg and sulpyrine 500mg) for spastic pain due to ureteral calculus was studied by double blind comparative analysis. SB-S02 was given intravenously to 43 patients. And an active placebo(N-butylscopolamine bromide 20mg) as a control drug was given samely to 42 patients. It was statistically proved that SB-502 relieved pain more efficiently than the active placebo. Two patients of SB-S02 group and 3 patients of the placebo group showed side effects. But the side effects were not significant.
- 泌尿器科紀要刊行会の論文
泌尿器科紀要刊行会 | 論文
- MVAC療法後の転移性尿路上皮癌に対するGemcitabine, Docetaxel, Carboplatin併用化学療法の検討
- Grade 3 Ta-1表在性膀胱癌に対する膀胱温存治療
- 腹腔鏡下に摘出した後腹膜神経線維腫の1例
- 移植腎生検による腎内動脈瘤破裂の1例
- Modified M-VAC療法後に残存腫瘍切除を施行した進行尿路上皮癌患者の治療成績